ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Gene therapy shows ‘mind-blowing’ success in treating haemophilia A – BioNews

Continue reading

2017-12-18 Michael Zand NEWS

Cambridge BioMarketing Discusses Outlook for Gene Therapy and CAR-T Treatments in 2018 – Business Wire (press release)

Cambridge BioMarketing Discusses Outlook for Gene Therapy and CAR-T Treatments in 2018Business Wire (press release)It will be more important than ever for healthcare companies to incorporate the hyperpersonalized experience in marketing and communicati… Continue reading

2017-12-18 Michael Zand NEWS

Immunotherapy closing in on a cure for cancer – WKYC-TV

Gene therapy shows ‘mind-blowing’ success in treating haemophilia A
BioNews
All seven patients who received the high-dose therapy to correct a faulty gene for a crucial blood clotting protein showed considerable improvement. ‘This is huge,’ Professor John Pasi, who led the trial at Barts and Queen Mary University of London …

Continue reading

2017-12-18 Michael Zand NEWS

Obesity epidemic: Could gene therapy be an answer? – Genetic Literacy Project

Genetic Literacy ProjectObesity epidemic: Could gene therapy be an answer?Genetic Literacy ProjectIn the case of obesity, scientists are trying to manipulate the genes that control how much fat we store in adipose tissue and how much energy we burn dur… Continue reading

2017-12-18 Michael Zand NEWS

Gilead’s CAR T-Cell Therapy Administered to Just Five Patients in Two Months – The Scientist


WKYC-TV

Immunotherapy closing in on a cure for cancer
WKYC-TV
The immunotherapy trials are taking place in select cities across the United States, but people who live in Kentuckiana don’t have to travel far to get on the list. It’s happening right now at the James Graham Brown Cancer Center. James Long has spent …

Continue reading

2017-12-18 Michael Zand NEWS

Regeneron pairs PD-1 latecomer with ISA’s HPV immunotherapy – FierceBiotech


The Scientist

Gilead’s CAR T-Cell Therapy Administered to Just Five Patients in Two Months
The Scientist
Originally developed by Kite Pharma—a California-based startup that was bought by Gilead for nearly $12 billion in cash earlier this year—Yescarta is just the second CAR T-cell therapy to be approved in the U.S. Doctors at the 15 cancer hospitals …

Continue reading

2017-12-18 Michael Zand NEWS

Mature Cell Discovery Could Cause a Rethink on the Origins of Cancer – Genetic Engineering & Biotechnology News


FierceBiotech

Regeneron pairs PD-1 latecomer with ISA’s HPV immunotherapy
FierceBiotech
… cancers like cervical and head-and-neck cancer, say the two companies. The Leiden-based company’s immunotherapy is aimed at HPV16, a strain of the virus that is thought to be responsible for 55% of human cervical cancers and premalignant lesions …
Regeneron and ISA Pharmaceuticals Announce Strategic Immuno-Oncology CollaborationMarkets Insider
Dutch and US Biotechs Team Up Against HPV-related CancerLabiotech.eu (blog)
Regeneron teams up with ISA Pharma to develop immunotherapeutic targeting HPV16-induced cancerSeeking Alpha

all 5 news articles »

Continue reading

2017-12-18 Michael Zand NEWS

Cancer treatment without chemotherapy? CAR T-cells could become the new standard – Genetic Literacy Project

Genetic Literacy ProjectCancer treatment without chemotherapy? CAR T-cells could become the new standardGenetic Literacy ProjectAlthough rare, it is not unheard-of for new treatments to achieve substantial early successes in one or two patients only to… Continue reading

2017-12-18 Michael Zand NEWS
  • 1
  • …
  • 772
  • 773
  • 774
  • 775
  • 776
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Genetic Engineering & Biotechnology News

Mature Cell Discovery Could Cause a Rethink on the Origins of Cancer
Genetic Engineering & Biotechnology News
Cancer therapies often target cells that grow and divide rapidly, such as stem cells, but in studying how stomach cancers occur, researchers at Washington University School of Medicine in St. Louis found that even when the stomach can’t make stem cells …
Stem Cell Banking Market Expected to Grow Rapidly with Size, Share, Demand and Revenue in International Market …Medgadget (blog)
Mature cells also play role in initiating cancer, study suggestsNews-Medical.net
Stem Cell Market Growth Analysis by Manufacturers, Market Status, And Competition Trend Forecast 2022Expert Herald
ExpressObserver –MilTech
all 14 news articles »